Relapse after discontinuing omalizumab is common in adolescents with chronic spontaneous urticaria, with early onset of disease and longer duration of pretreatment symptoms linked to recurrence.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/omalizumab-break-tied-urticaria-relapse-risk-teens-2025a1000qvp?src=rss
Author :
Publish date : 2025-10-07 05:56:00
Copyright for syndicated content belongs to the linked Source.
